70 related articles for article (PubMed ID: 32555031)
1. Report of 2 Pediatric Cases With Li-Fraumeni Syndrome Related Malignancy in a Family.
Takeoka M; Toyoda H; Hirayama J; Suzuki N; Hanaki R; Amano K; Iwamoto S; Hirayama M
J Pediatr Hematol Oncol; 2021 May; 43(4):e567-e570. PubMed ID: 32555031
[TBL] [Abstract][Full Text] [Related]
2. Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort.
Mai PL; Best AF; Peters JA; DeCastro RM; Khincha PP; Loud JT; Bremer RC; Rosenberg PS; Savage SA
Cancer; 2016 Dec; 122(23):3673-3681. PubMed ID: 27496084
[TBL] [Abstract][Full Text] [Related]
3. SEOM clinical guideline on heritable TP53-related cancer syndrome (2022).
Sánchez-Heras AB; Ramon Y Cajal T; Pineda M; Aguirre E; Graña B; Chirivella I; Balmaña J; Brunet J;
Clin Transl Oncol; 2023 Sep; 25(9):2627-2633. PubMed ID: 37133731
[TBL] [Abstract][Full Text] [Related]
4. TP53 p.R337H is a conditional cancer-predisposing mutation: further evidence from a homozygous patient.
Giacomazzi J; Selistre S; Duarte J; Ribeiro JP; Vieira PJ; de Souza Macedo G; Rossi C; Czepielewski M; Netto CB; Hainaut P; Ashton-Prolla P
BMC Cancer; 2013 Apr; 13():187. PubMed ID: 23570263
[TBL] [Abstract][Full Text] [Related]
5. Two TP53 germline mutations in a classical Li-Fraumeni syndrome family.
van Hest LP; Ruijs MW; Wagner A; van der Meer CA; Verhoef S; van't Veer LJ; Meijers-Heijboer H
Fam Cancer; 2007; 6(3):311-6. PubMed ID: 17318340
[TBL] [Abstract][Full Text] [Related]
6. Li Fraumeni Syndrome predisposes to gastro-esophageal junction tumours.
Tjandra D; Boussioutas A
Fam Cancer; 2024 Mar; 23(1):29-33. PubMed ID: 38206485
[TBL] [Abstract][Full Text] [Related]
7. Spectrum and Excess Risk of Gastrointestinal Tumors in Li-Fraumeni Syndrome.
Hatton JN; de Andrade KC; Frone MN; Savage SA; Khincha PP
Clin Gastroenterol Hepatol; 2024 Mar; 22(3):662-665.e1. PubMed ID: 37714395
[TBL] [Abstract][Full Text] [Related]
8. Upper Gastrointestinal Cancer Risk and Surveillance Outcomes in Li-Fraumeni Syndrome.
Katona BW; Powers J; McKenna DB; Long JM; Le AN; Hausler R; Zelley K; Jennings S; Domchek SM; Nathanson KL; MacFarland SP; Maxwell KN
Am J Gastroenterol; 2020 Dec; 115(12):2095-2097. PubMed ID: 32969947
[TBL] [Abstract][Full Text] [Related]
9. Clinical Features of Li-Fraumeni Syndrome in Korea.
Song R; Kong SY; Choi W; Lee EG; Woo J; Han JH; Lee S; Kang HS; Jung SY
Cancer Res Treat; 2024 Jan; 56(1):334-341. PubMed ID: 37562436
[TBL] [Abstract][Full Text] [Related]
10. Early Cancer Detection in Li-Fraumeni Syndrome with Cell-Free DNA.
Wong D; Luo P; Oldfield LE; Gong H; Brunga L; Rabinowicz R; Subasri V; Chan C; Downs T; Farncombe KM; Luu B; Norman M; Sobotka JA; Uju P; Eagles J; Pedersen S; Wellum J; Danesh A; Prokopec SD; Stutheit-Zhao EY; Znassi N; Heisler LE; Jovelin R; Lam B; Lujan Toro BE; Marsh K; Sundaravadanam Y; Torti D; Man C; Goldenberg A; Xu W; Veit-Haibach P; Doria AS; Malkin D; Kim RH; Pugh TJ
Cancer Discov; 2024 Jan; 14(1):104-119. PubMed ID: 37874259
[TBL] [Abstract][Full Text] [Related]
11. Is It Time to Incorporate Liquid Biopsy into High-Risk Cancer Surveillance Protocols in Li-Fraumeni Syndrome?
Latham A; MacFarland SP; Walsh MF; Maxwell KN; Stadler ZK
Cancer Discov; 2024 Jan; 14(1):23-25. PubMed ID: 38213298
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome.
Kolodziejczak AS; Guerrini-Rousseau L; Planchon JM; Ecker J; Selt F; Mynarek M; Obrecht D; Sill M; Autry RJ; Stutheit-Zhao E; Hirsch S; Amouyal E; Dufour C; Ayrault O; Torrejon J; Waszak SM; Ramaswamy V; Pentikainen V; Demir HA; Clifford SC; Schwalbe EC; Massimi L; Snuderl M; Galbraith K; Karajannis MA; Hill K; Li BK; Walsh M; White CL; Redmond S; Loizos L; Jakob M; Kordes UR; Schmid I; Hauer J; Blattmann C; Filippidou M; Piccolo G; Scheurlen W; Farrag A; Grund K; Sutter C; Pietsch T; Frank S; Schewe DM; Malkin D; Ben-Arush M; Sehested A; Wong TT; Wu KS; Liu YL; Carceller F; Mueller S; Stoller S; Taylor MD; Tabori U; Bouffet E; Kool M; Sahm F; von Deimling A; Korshunov A; von Hoff K; Kratz CP; Sturm D; Jones DTW; Rutkowski S; van Tilburg CM; Witt O; Bougeard G; Pajtler KW; Pfister SM; Bourdeaut F; Milde T
Neuro Oncol; 2023 Dec; 25(12):2273-2286. PubMed ID: 37379234
[TBL] [Abstract][Full Text] [Related]
13. Embodied risk for families with Li-Fraumeni syndrome: Like electricity through my body.
Werner-Lin A; Forbes Shepherd R; Young JL; Wilsnack C; Merrill SL; Greene MH; Khincha PP
Soc Sci Med; 2022 May; 301():114905. PubMed ID: 35367908
[TBL] [Abstract][Full Text] [Related]
14. Pleomorphic dermal sarcoma presenting in a child with Li-Fraumeni syndrome: A case report and review of the literature.
Kim H; Noh H; Shim J; Oh SJ; Lee JH; Lee DY; Park JH
Pediatr Dermatol; 2024; 41(2):311-314. PubMed ID: 38014598
[TBL] [Abstract][Full Text] [Related]
15. Li-Fraumeni syndrome: cancer risk assessment and clinical management.
McBride KA; Ballinger ML; Killick E; Kirk J; Tattersall MH; Eeles RA; Thomas DM; Mitchell G
Nat Rev Clin Oncol; 2014 May; 11(5):260-71. PubMed ID: 24642672
[TBL] [Abstract][Full Text] [Related]
16. LFSPROShiny: An Interactive R/Shiny App for Prediction and Visualization of Cancer Risks in Families With Deleterious Germline
Nguyen NH; Dodd-Eaton EB; Peng G; Corredor JL; Jiao W; Woodman-Ross J; Arun BK; Wang W
JCO Clin Cancer Inform; 2024 Feb; 8():e2300167. PubMed ID: 38346271
[TBL] [Abstract][Full Text] [Related]
17. Lack of Association Between oral Squamous cell Carcinoma and Li-Fraumeni Syndrome.
Dos Santos ES; Santos-Silva AR
Head Neck Pathol; 2023 Mar; 17(1):277-278. PubMed ID: 36344907
[No Abstract] [Full Text] [Related]
18. Factors affecting adherence to a high-risk surveillance protocol among patients with Li-Fraumeni syndrome.
Underkofler KA; Thomas MH; Taylor CJ; Mazur CL; Erickson SH; Ring KL
Hered Cancer Clin Pract; 2023 Aug; 21(1):15. PubMed ID: 37568169
[TBL] [Abstract][Full Text] [Related]
19. Pediatric Head and Neck Tumors Associated with Li-Fraumeni Syndrome.
Rodriguez KD; Schneider KW; Suttman A; Garrington T; Jellins T; Tholen K; Francom CR; Herrmann BW
Ann Otol Rhinol Laryngol; 2022 Feb; 131(2):159-163. PubMed ID: 33971750
[TBL] [Abstract][Full Text] [Related]
20. Molecular genotyping of adrenocortical carcinoma: a systematic analysis of published literature 2019-2021.
Grisanti S; Cosentini D; Sigala S; Berruti A
Curr Opin Oncol; 2022 Jan; 34(1):19-28. PubMed ID: 34669649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
